Article
Optimising the care and quality of life of people with cystic fibrosis: the influence of cystic fibrosis transmembrane conductance regulator modulators.
British journal of hospital medicine (London, England : 2005) - 2 Nov 2021
Shaw Nicola, Collins Sarah, Smith Thomas, McCulloch Anna, Ketchell Ian, Edwards Viv, Blaikie Lesley, Daniels Tracey
Abstract excerpt
Cystic fibrosis is a life-limiting, inherited, multi-organ disease which affects many systems of the body. Until recently, treatments were only able to ameliorate symptoms, but the introduction of precision medications which modulate the underlying defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene has changed this. Notably improvements in nutrition and lung function, reduced use of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
